SVB Wealth LLC lessened its position in shares of Danaher Corporation (NYSE:DHR – Free Report) by 19.4% during the first quarter, Holdings Channel reports. The institutional investor owned 13,365 shares of the conglomerate’s stock after selling 3,227 shares during the quarter. SVB Wealth LLC’s holdings in Danaher were worth $2,534,000 as of its most recent filing with the Securities and Exchange Commission (SEC).
Several other large investors also recently added to or reduced their stakes in the company. Atlas Brown Inc. lifted its stake in shares of Danaher by 3.4% during the 1st quarter. Atlas Brown Inc. now owns 3,305 shares of the conglomerate’s stock valued at $627,000 after buying an additional 109 shares in the last quarter. PKO Investment Management Joint Stock Co grew its position in shares of Danaher by 5.7% in the first quarter. PKO Investment Management Joint Stock Co now owns 9,200 shares of the conglomerate’s stock valued at $1,744,000 after purchasing an additional 500 shares in the last quarter. Generate Investment Management Ltd bought a new stake in shares of Danaher during the first quarter valued at about $13,093,000. Ocean Park Asset Management LLC bought a new stake in Danaher during the 1st quarter worth approximately $262,000. Finally, XML Financial LLC increased its holdings in shares of Danaher by 3.2% in the first quarter. XML Financial LLC now owns 7,886 shares of the conglomerate’s stock worth $1,495,000 after purchasing an additional 242 shares during the period. Hedge funds and other institutional investors own 79.05% of the company’s stock.
Danaher Price Performance
Shares of Danaher stock opened at $178.22 on Tuesday. The company has a current ratio of 1.87, a quick ratio of 1.52 and a debt-to-equity ratio of 0.33. The firm has a market capitalization of $126.14 billion, a PE ratio of 34.47, a price-to-earnings-growth ratio of 2.26 and a beta of 0.81. The business’s 50-day moving average price is $179.32 and its 200-day moving average price is $202.58. Danaher Corporation has a 12 month low of $160.93 and a 12 month high of $242.80.
Danaher Dividend Announcement
The firm also recently disclosed a quarterly dividend, which will be paid on Friday, July 31st. Stockholders of record on Friday, June 26th will be issued a $0.40 dividend. This represents a $1.60 dividend on an annualized basis and a dividend yield of 0.9%. The ex-dividend date is Friday, June 26th. Danaher’s payout ratio is presently 30.95%.
Analyst Upgrades and Downgrades
DHR has been the subject of a number of research analyst reports. Jefferies Financial Group reiterated a “buy” rating and set a $245.00 price target on shares of Danaher in a research report on Tuesday, April 21st. Morgan Stanley dropped their target price on shares of Danaher from $270.00 to $255.00 and set an “overweight” rating for the company in a research report on Wednesday, April 22nd. Rothschild & Co Redburn set a $205.00 price target on shares of Danaher in a research note on Friday, April 17th. Evercore increased their price target on shares of Danaher from $225.00 to $232.00 and gave the stock an “outperform” rating in a report on Tuesday, April 21st. Finally, JPMorgan Chase & Co. lowered their price objective on shares of Danaher from $275.00 to $245.00 and set an “overweight” rating on the stock in a research report on Wednesday, April 22nd. One research analyst has rated the stock with a Strong Buy rating, nineteen have issued a Buy rating and five have assigned a Hold rating to the company. According to data from MarketBeat, the company has a consensus rating of “Moderate Buy” and an average price target of $233.61.
Check Out Our Latest Stock Report on DHR
Danaher Profile
Danaher Corporation (NYSE: DHR) is a global science and technology company that designs, manufactures and markets products and services for the life sciences, diagnostics, and environmental and applied markets. The company organizes its operations into business segments focused on Life Sciences, Diagnostics, and Environmental & Applied Solutions, supplying instruments, reagents, software and related services that support research, clinical testing, biopharmaceutical development, and industrial and environmental monitoring.
Products and services in Danaher’s portfolio include analytical and diagnostic instruments, laboratory consumables and reagents, digital and software solutions for workflow and data management, field and industrial monitoring equipment, and service and maintenance programs.
Further Reading
- Five stocks we like better than Danaher
- Buy CrowdStrike Before the Stock Split? Here’s the Case
- Investors Are Buying Into Sweetgreen Again—Should They?
- Burlington Is Winning Over Shoppers But Investors Need Patience
- USA Today’s Digital Revival Is Gaining Steam, But With Plenty of Risk
Want to see what other hedge funds are holding DHR? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Danaher Corporation (NYSE:DHR – Free Report).
Receive News & Ratings for Danaher Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Danaher and related companies with MarketBeat.com's FREE daily email newsletter.
